Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Longevity Metrics AI/ML Development Study: A Standing Data Library and Model-Development Platform for Predicting and Validating Health Measurements, Longevity, and Disease
Authors not listed
Longevity Metrics, Inc. · 2026
Abstract
This study builds AI models that score diagnostic screening tests, and that predict screening results, clinical judgment, and life expectancy. Longevity Metrics collects a battery of clinical tests on each participant, in whole or in part, and follows every participant for life.
The sit-to-rise test and the timed walk are scored by hand today, from a person's count. A model scores the same test from video instead. It also measures what no one can count by eye - speed, asymmetry, steadiness - so one capture yields both the original score and additional measurements, intended to enrich the model and strengthen what it predicts.
Every test in a participant's record measures the same body, so the tests are correlated: a test that was performed carries information about one that was not. A model trained across the library learns those relationships and estimates a missing result from the results that are present. Each estimate is checked against records where that part was actually measured, and over decades against death and disease through linkage to the 100-Year Human Aging Study (NCT07563777).
The hypothesis is that the full battery can eventually be predicted across modalities with high accuracy using a few short video clips, replacing most in-person screening. That would let preventive screening reach people and places a physical laboratory cannot. How far the input can be reduced is the question this study exists to answer.
Every model is a physician-reviewed clinical decision aid until it is cleared by the FDA.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-13 MST
Cite this
APA
Anonymous. (2026). Longevity Metrics AI/ML Development Study: A Standing Data Library and Model-Development Platform for Predicting and Validating Health Measurements, Longevity, and Disease. <em>Longevity Metrics, Inc.</em>. https://clinicaltrials.gov/study/NCT07808619
Vancouver
Anonymous. Longevity Metrics AI/ML Development Study: A Standing Data Library and Model-Development Platform for Predicting and Validating Health Measurements, Longevity, and Disease. Longevity Metrics, Inc.. 2026.
BibTeX
@misc{anon2026Longev,
title = {Longevity Metrics AI/ML Development Study: A Standing Data Library and Model-Development Platform for Predicting and Validating Health Measurements, Longevity, and Disease},
author = {Anonymous},
journal = {Longevity Metrics, Inc.},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Geriatrics 2025
Open access · CC-BY
A cohort study of growth differentiating factor − 15 (GDF-15) and Interleukin-6 (IL-6) as biomarkers of healthy aging in older adults living with HIV
BMC geriatrics 2025
Open access · OA
A cohort study of growth differentiating factor - 15 (GDF-15) and Interleukin-6 (IL-6) as biomarkers of healthy aging in older adults living with HIV.
Figshare 2026
Preprint · CC-BY
A cohort study of growth differentiating factor − 15 (GDF-15) and Interleukin-6 (IL-6) as biomarkers of healthy aging in older adults living with HIV
The EMBO Journal 2017
Open access · CC-BY
APP mouse models for Alzheimer's disease preclinical studies
The Journals of Gerontology Series A 2020
Preprint · OA
Assessment of Epigenetic Clocks as Biomarkers of Aging in Basic and Population Research
Frontiers in Genetics 2019
Open access · CC-BY